The Center for Healthcare Value (CHV)

The Center for Healthcare Value
The Center for Healthcare Value (CHV) is focused on advancing rational, science-driven and clinician-tested healthcare solutions that reduce cost and improve quality.
Training: Teaching to Choose Wisely
The CHV Training Initiative is reshaping clinical education to ensure the next generation of healthcare leaders understand the importance of value and how to create it.
Caring Wisely™
Caring Wisely is an organized process for engaging and supporting frontline clinicians in efforts to remove unnecessary costs from healthcare delivery systems.

Research and Policy
The CHV Research and Policy Initiative supports multi-center and multi-stakeholder projects that define high-value care and incentivize its adoption to demonstrate that value can be improved across the system
Delivery Systems: Measuring Value
The CHV Measuring Value Initiative is a partnership between front-line practitioners, financial data analysts, and executive stakeholders to build a standardized approach to accurately assess the clinical benefits and cost savings of value-based initiatives at UCSF.

Reduce costs | Increase value | Enable innovation

Featured stories:

Soaring Drug Prices: How They Impact Consumers and What Can Be Done

Drug pricesDrug prices in the United States are twice what they are in the United Kingdom and are much higher than in all other developed countries. In addition, drug prices are rising faster than prices for general consumer products or even other health care products. In this panel, Lisa Gill from Consumer Reports will describe the impact on patients.  R. Adams Dudley, MD, from UCSF, will describe the consequences of high or expensive drug costs on patients with severe or chronic health conditions.  Finally, Robin Feldman from UC Hastings will outline the role of patent law and market forces in driving prices higher. The panel and the audience will then discuss policy options to address high drug prices.

Video: UCSF Presentation by Lisa Gill and R. Adams Dudley, MD
Video: Capitol Insights: A UC Center Sacramento Panel Discussion


 

Trumpcare: Is it the Right Treatment for what Ails the American Health Care System?

All health care systems must strike a delicate balance between cost, quality and access. While Obamacare focused largely on increasing access to coverage and spreading the cost of illness across the entire population, Trumpcare tips the balance largely in favor of reducing federal spending, at the risk of destabilizing insurance markets and increasing costs for older and sicker individuals. (View video)  
 


Pelvic Exams Effect of professional society recommendations on women's desire for a routine pelvic examination

One group of doctors, represented by the American College of Obstetricians and Gynecologists, recommends yearly pelvic exams for all women 21 years of age and older, whether they have symptoms of disease or not.

But the American College of Physicians, representing doctors of internal medicine, says that potential harms of the exam outweigh benefits and recommends against performing pelvic examinations unless a woman is pregnant or has symptoms of disease such as bleeding, pain or signs of infection.
 


Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Patients

About half of U.S. doctors received payments from the pharmaceutical and medical device industries in 2015, amounting to $2.4 billion, a new study reports.

Those payments and gifts very likely encourage doctors to prescribe pricey brand-name drugs and devices pushed by sales representatives, a second study argues. Doctors at academic medical centers were more likely to prescribe cheaper generic drugs than expensive brand-name drugs after their hospitals adopted rules that restricted pharmaceutical sales visits, the researchers said.